In this episode we talk about updates in the diabetes landscape, most notable with Ozempic and some SGLT2 products. We also discuss approval of Valtoco for seizure rescue treatment, Tepezza for thyroid eye disease, and Tavzerik for epithelioid sarcoma. We also give updates on the FDA drug watchlist, and an overview of whats going on with the emerging Coronavirus out of China. Don't forget to share & subscribe to keep the momentum going! Thanks for listening!